Nippon Shinyaku’s R&D Activities
By implementing our own drug discovery research, licensing-in from other companies and product lifecycle management (PLCM), we are striving to speedily launch pharmaceuticals to help patients.
Discovery Research Laboratories at our headquarters in Kyoto and Discovery Research Laboratories in Tsukuba, Ibaraki Prefecture, are jointly exploring new pharmaceutical leads.
Head Office /
Discovery Research Laboratories /
Food Development Laboratories
14, Nishinosho-Monguchi-cho, Kisshoin,
Minami-ku, Kyoto 601-8550, Japan
Discovery Research Laboratories in
14-1, Sakura 3-chome, Tsukuba 305-
Our pharmaceutical R&D organization consists of R&D Administration, Business Development, Discovery Research Laboratories and Clinical Development.
In Discovery Research Laboratories in Kyoto, we focus on small-molecule research, the safety and pharmacokinetics of drug seeds in animals, formulation development, pilot synthesis, and the establishment of our proprietary formulation technology. In Discovery Research Laboratories in Tsukuba, we conduct advanced research centered on genomic drug discovery and nucleic acid drugs.
The Clinical Development Division is in charge of clinical trials to evaluate the safety and efficacy of pharmaceuticals in humans.
The Licensing & Alliance Division has responsibility for licensing in and out.
Strategy , Vision
We are focusing our R&D on four areas of specialty: urology, hematology, intractable/rare diseases and gynecology. By implementing our own drug discovery research, licensing-in from other companies and product lifecycle management (PLCM), we are striving to speedily launch pharmaceuticals to help patients.